Openbookopenbook
Equity
Positron Corp(POSC)
USD --+0.00%
Reward34Low
Risk77High
📊75%Data
Revenue down 18% YoY
POSC
+0.0 · +0.00%
USD · PINK
Positron Corp | Healthcare
Earnings Deterioration
Market Cap:78.48M
ℹ️
Reward Rating
34
Low
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
77
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on POSC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Positron Corp?

Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States.

POSC · Verdict

Limited reward · high risk

POSC stands out on valuation and volatility, but watch the balance sheet signal.

Based on 88% data coverage

POSC · Verdict

What’s working & what to watch

Strengths 2

  • Valuation67/100

    Above average

  • Volatility65/100

    Above average

Watchouts 4

  • Balance sheet6/100

    Current ratio 0.62

  • Profitability9/100

    -406% net margin · 0% ROE

  • Cash flow9/100

    -295% free-cash-flow margin

  • Growth25/100

    Rev -12.7% CAGR · earnings +58.9%

Model-based scoring. For information only — not financial advice.

What is Positron Corp?

Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 78.48M, and a P/E ratio of 0.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Low (34)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap78.48M
P/E Ratio0.3686
Dividend YieldN/A
52 Week High2.74
52 Week Low1.22
Last AnnualDecember
IPO Date12/3/1993
IncorporatedUSA
Shares Outstanding31M
No. of Employees10
IndustryMedical Devices
ExchangePINK
Beta0.748
CurrencyUSD
Websitewww.positron.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.